We are live on ! Find out more
NGM

NGM Biopharmaceuticals, Inc. Common Stock

Delisted

NGM was delisted on the 4th of April, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
PS
1
Peter Svennilson
$350M +$7.34M +383,834 +2%
RCP
2
Rho Capital Partners
New York
$74.4M
BlackRock
3
BlackRock
New York
$45.1M +$649K +33,968 +2%
GA
4
Greenspring Associates
Maryland
$31.1M
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$30.1M +$10.1M +527,290 +53%
Vanguard Group
6
Vanguard Group
Pennsylvania
$27.8M +$17.9M +934,972 +197%
ACM
7
Aquilo Capital Management
California
$21.6M +$917K +48,000 +5%
State Street
8
State Street
Massachusetts
$9.17M +$107K +5,574 +1%
RSCM
9
Rock Springs Capital Management
Maryland
$7.05M +$121K +6,309 +2%
JRP
10
Jasper Ridge Partners
California
$6.09M
Northern Trust
11
Northern Trust
Illinois
$5.17M -$52.8K -2,763 -1%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$4.82M +$183K +9,592 +4%
CS
13
Candriam SCA
Luxembourg
$4.52M -$253K -13,236 -5%
JP Morgan Chase
14
JP Morgan Chase
New York
$4.31M -$480K -25,091 -10%
Jacobs Levy Equity Management
15
Jacobs Levy Equity Management
New Jersey
$3.94M +$1.17M +61,432 +45%
Morgan Stanley
16
Morgan Stanley
New York
$3.66M +$3.49M +182,634 +6,326%
Renaissance Technologies
17
Renaissance Technologies
New York
$3.34M +$380K +19,900 +13%
BBA
18
Baker Bros. Advisors
New York
$2.46M -$2.4M -125,600 -50%
Nuveen
19
Nuveen
North Carolina
$2.21M -$44.3K -2,320 -2%
Wells Fargo
20
Wells Fargo
California
$1.65M +$892K +46,661 +126%
SG Americas Securities
21
SG Americas Securities
New York
$1.63M +$1.37M +71,842 +684%
Charles Schwab
22
Charles Schwab
California
$1.62M +$25.9K +1,354 +2%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$1.6M -$21.1K -1,106 -1%
Arrowstreet Capital
24
Arrowstreet Capital
Massachusetts
$1.6M +$1.55M +81,016 New
Goldman Sachs
25
Goldman Sachs
New York
$1.19M +$303K +15,863 +36%